2024-04-07 10:21:56 ET
Summary
- ResMed's shares have seen setbacks but still trade at a healthy premium compared to the market, less of a premium compared to the past.
- The company targets large and growing addressable markets, including sleep apnea, COPD, asthma, and insomnia.
- ResMed has steadily grown over the past decade and has a positive long-term outlook despite some concerns.
Shares of ResMed ( RMD ) have seen some setbacks in recent years, even as the company has seen continued growth, with its major peer suffering some turmoil itself, amidst massive recalls and related problems....
Read the full article on Seeking Alpha
For further details see:
ResMed: Not A Sleeper